These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35393453)

  • 1. SH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding.
    Brian BF; Sjaastad FV; Freedman TS
    Sci Rep; 2022 Apr; 12(1):5875. PubMed ID: 35393453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.
    Trible RP; Emert-Sedlak L; Smithgall TE
    J Biol Chem; 2006 Sep; 281(37):27029-38. PubMed ID: 16849330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells.
    Davidson D; Cloutier JF; Gregorieff A; Veillette A
    J Biol Chem; 1997 Sep; 272(37):23455-62. PubMed ID: 9287362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.
    Fiorillo E; Orrú V; Stanford SM; Liu Y; Salek M; Rapini N; Schenone AD; Saccucci P; Delogu LG; Angelini F; Manca Bitti ML; Schmedt C; Chan AC; Acuto O; Bottini N
    J Biol Chem; 2010 Aug; 285(34):26506-18. PubMed ID: 20538612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src family kinases: regulation of their activities, levels and identification of new pathways.
    Ingley E
    Biochim Biophys Acta; 2008 Jan; 1784(1):56-65. PubMed ID: 17905674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling.
    Rubbi L; Titz B; Brown L; Galvan E; Komisopoulou E; Chen SS; Low T; Tahmasian M; Skaggs B; Müschen M; Pellegrini M; Graeber TG
    Sci Signal; 2011 Mar; 4(166):ra18. PubMed ID: 21447799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
    Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
    Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTPN22 phosphorylation acts as a molecular rheostat for the inhibition of TCR signaling.
    Yang S; Svensson MND; Harder NHO; Hsieh WC; Santelli E; Kiosses WB; Moresco JJ; Yates JR; King CC; Liu L; Stanford SM; Bottini N
    Sci Signal; 2020 Mar; 13(623):. PubMed ID: 32184287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative role of caveolin-1 and C-terminal Src kinase binding protein in C-terminal Src kinase-mediated negative regulation of c-Src.
    Place AT; Chen Z; Bakhshi FR; Liu G; O'Bryan JP; Minshall RD
    Mol Pharmacol; 2011 Oct; 80(4):665-72. PubMed ID: 21778303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new interaction mode between the Src homology 2 domain of C-terminal Src kinase (Csk) and Csk-binding protein/phosphoprotein associated with glycosphingolipid microdomains.
    Tanaka H; Akagi K; Oneyama C; Tanaka M; Sasaki Y; Kanou T; Lee YH; Yokogawa D; Dobenecker MW; Nakagawa A; Okada M; Ikegami T
    J Biol Chem; 2013 May; 288(21):15240-54. PubMed ID: 23548896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors.
    Davidson D; Zhong MC; Pandolfi PP; Bolland S; Xavier RJ; Seed B; Li X; Gu H; Veillette A
    Cell Rep; 2016 Dec; 17(10):2776-2788. PubMed ID: 27926878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
    Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
    Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence requirements for association of protein-tyrosine phosphatase PEP with the Src homology 3 domain of inhibitory tyrosine protein kinase p50(csk).
    Gregorieff A; Cloutier JF; Veillette A
    J Biol Chem; 1998 May; 273(21):13217-22. PubMed ID: 9582365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22.
    Wallis AM; Wallace EC; Hostager BS; Yi Z; Houtman JCD; Bishop GA
    Sci Rep; 2017 May; 7(1):2081. PubMed ID: 28522807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
    Potuckova L; Draberova L; Halova I; Paulenda T; Draber P
    Front Immunol; 2018; 9():1771. PubMed ID: 30116247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the SRC family kinases by Csk.
    Okada M
    Int J Biol Sci; 2012; 8(10):1385-97. PubMed ID: 23139636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
    Chong YP; Mulhern TD; Cheng HC
    Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: Fyn is essential for tyrosine phosphorylation of Csk-binding protein/phosphoprotein associated with glycolipid-enriched microdomains in lipid rafts in resting T cells.
    Yasuda K; Nagafuku M; Shima T; Okada M; Yagi T; Yamada T; Minaki Y; Kato A; Tani-Ichi S; Hamaoka T; Kosugi A
    J Immunol; 2002 Sep; 169(6):2813-7. PubMed ID: 12218089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of FRET Biosensor to Characterize CSK Subcellular Regulation.
    Ouyang M; Xing Y; Zhang S; Li L; Pan Y; Deng L
    Biosensors (Basel); 2024 Apr; 14(4):. PubMed ID: 38667199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.